Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma

ConclusionThe real-world efficacy of RIT is comparable with the results of the MIR study. Additionally, this analysis shows that extranodal involvement and grade 3A  histology are not associated with inferior PFS.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research